Trial Profile
An Observational, single-arm study to evaluate the outcomes of cinacalcet treatment with or without active vitamin D for secondary hyperparathyroidism in hemodialysis and peritoneal dialysis patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Mar 2018
Price :
$35
*
At a glance
- Drugs Cinacalcet (Primary) ; Vitamin D
- Indications Secondary hyperparathyroidism
- Focus Therapeutic Use
- Acronyms TRANSIT
- Sponsors Amgen
- 21 Mar 2018 New trial record